The Risk of Subsequent Miscarriage in Pregnant Women with Prior Polycystic Ovarian Syndrome: A Nationwide Population-Based Study
Open Access
- 4 August 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (16) , 8253
Abstract
Objective: To assess the risk of subsequent miscarriage in pregnant women with a prior diagnosis of polycystic ovarian syndrome (PCOS). Methods: Using a nationwide, population-based database (Taiwan National Health Insurance Research Database) during 1998–2012, the study retrieved 1,000,000 randomly-sampled insured citizens as research subjects. The women with a diagnosis of pre-pregnancy PCOS (n = 13,562) who had chromosomal anomalies, artificial abortion, inconsistent diagnoses, and who were initially diagnosed with PCOS at >45 or Results: Pregnant women with prior PCOS (the case group; n = 1926) and those without prior PCOS (the control group; n = 7704) were compared. The incidence of subsequent miscarriage was much higher in the case group compared with the control group (33.80% vs. 4.09%, p < 0.0001). Logistic regression analysis revealed that the risk of subsequent miscarriage was significantly higher in the case group than the control group (odds ratio [OR] 11.98; 95% CI 10.34–13.87, p < 0.0001), and the result remained similar while adjusted with covariates (adjusted OR 11.97; 95% CI 10.27–13.95, p < 0.0001). In the case group, the patient who used metformin had a lower risk of subsequent miscarriage (adjusted OR 9.53; 95% CI 6.69–13.57) when compared with those who did not receive metformin treatment (adjusted OR 12.13; 95% CI 10.38–14.18). Conclusion: For pregnant women, a pre-pregnancy diagnosis of PCOS is an independent and significant risk factor for subsequent miscarriage. The risk of subsequent miscarriage is reduced by about 1/4 for the PCOS patients who undergo metformin treatment compared with those who do not.Keywords
Funding Information
- Taipei Tzu Chi Hospital (TCRD-TPE-110-06)
This publication has 40 references indexed in Scilit:
- Low-grade chronic inflammation in the peripheral blood and ovaries of women with polycystic ovarian syndromeEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2011
- FMR1 Genotype with Autoimmunity-Associated Polycystic Ovary-Like Phenotype and Decreased Pregnancy ChancePLOS ONE, 2010
- Down-regulation of progesterone receptor membrane component 1 (PGRMC1) in peripheral nucleated blood cells associated with premature ovarian failure (POF) and polycystic ovary syndrome (PCOS)Reproductive Biology and Endocrinology, 2010
- The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteriaHuman Reproduction, 2009
- Construction of a polycystic ovarian syndrome (PCOS) pathway based on the interactions of PCOS-related proteins retrieved from bibliomic dataTheoretical Biology and Medical Modelling, 2009
- Metabolic disorders in patients with recent gestational diabetes mellitusJournal of Obstetrics and Gynaecology Research, 2006
- IgG, IgA and IgM Antibodies against FSH: Serological Markers of Pathogenic Autoimmunity or of Normal Immunoregulation?American Journal of Reproductive Immunology, 2005
- Polycystic ovary syndrome as an autoimmune disease: a new conceptObstetrics & Gynecology, 2000
- The Role of Insulin Resistance in Polycystic Ovary SyndromeThe Endocrinologist, 1996
- Circulating Tumor Necrosis Factor (TNF)‐α in Normally Cycling Women and Patients with Premature Ovarian Failure and Polycystic OvariesAmerican Journal of Reproductive Immunology, 1995